Proveca appoints former ABPI and AZ president
pharmafile | September 3, 2013 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | ABPI, AZ, Brinsmead, Proveca
The former president of AstraZeneca and the ABPI has been appointed as chairman of pharma firm Proveca.
Chris Brinsmead joins the Cheshire-based company which focusses on the re-engineering of existing medicines to make them appropriate for use by young people within Europe.
He brings with him over 30 years’ experience in the industry, which includes serving as the president of ABPI, advising the UK Government on life science policy and supporting a raft of pharma and medical companies across the country.
Proveca, which is based at Sci-Tech Daresbury, is currently developing medicines in the fields of cardiology, neurology and pain management, largely for children.
Brinsmead said: “It’s a tremendous honour to be taking this role at such a forward-thinking and progressive company.
“Proveca is consistently making strides in its field and I am confident that my experience and expertise will greatly help with its further development. I look forward to working with the team and playing a key role in the company’s exciting future.”
Proveca director Helen Shaw, the former medical director for Boots Healthcare International, said: “We are delighted to be gaining a chairman with such an unparalleled understanding of the pharmaceutical industry as Chris.
Co-director Simon Bryson added: “We’ve enjoyed a fantastic past year and he will be a valued asset to the company as we look to the future and take our pipeline of new products through the process of development.”
Related Content
AstraZeneca’s Calquence fails to improve survival rates in coronavirus patients
AstraZeneca’s Calquence has failed to improve survival rates and prevent lung failure in patients hospitalised …
The November 2020 issue of Pharmafocus is available to read free online now!
The latest monthly edition of Pharmafocus is available to read for free online now!
UK life sciences industry does not want no-deal Brexit, says ABPI Chief
Prime Minister Boris Johnson’s sudden change of position that the UK is now expecting a …
